AdAlta Limited Profile Avatar - Palmy Investing

AdAlta Limited

AdAlta Limited, a clinical stage biotechnology company, discovers and develops protein therapeutics in Australia. The company's lead i-body drug candidate includes AD-214, which is in Phase I clinical trials for the treatment of idiopathic pulmonary fibr…

Biotechnology
AU, Melbourne [HQ]

Government Awards Analysis Beta

Obligations Over-Time

Awards
Obligations

AdAlta Limited has no obligation with a government/award agency.

Latest Obligations

Contracts
$ 0.0
IDVs
$ 0.0
Direct Payments
$ 0.0
Grants
$ 0.0
Loans
$ 0.0
Other Payments
$ 0.0
vs. Previous FY
Contracts
$ 0.0
IDVs
$ 0.0
Direct Payments
$ 0.0
Grants
$ 0.0
Loans
$ 0.0
Other Payments
$ 0.0

Spending By Type

Awards
Obligations

AdAlta Limited can't present spending by time.

Get PRO Today

With PRO you will unlock all insights related to government awards of AdAlta Limited.

End of 1AD.AX's Analysis
CIK: - CUSIP: Q0101X107 ISIN: AU0000001AD2 LEI: - UEI: -
Secondary Listings
1AD.AX has no secondary listings inside our databases.